Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics establishes the Doto Medical special purpose vehicle and signs an agreement with the renowned international business advisor Clairfield Partners to accelerate the commercialization of the PB103 aptamer project.

News

Inquiries

Antibody E-Conference 13.10.2020 – invitation

10 November

2020

Antibody E-Conference 13.10.2020 – invitation

Pure Biologics antibody e-conference on November 13, 2020, 13:00!

Project PB001 – partner for preclinical research

5 November

2020

Project PB001 – partner for preclinical research

We chose a partner to carry out the first panel of preclinical studies in the PB001 project.

5 November

2020

Pure Biologics – new webpage!

The PB010 PureSelect2 project has been successfully completed!

30 October

2020

The PB010 PureSelect2 project has been successfully completed!

The aim was to develop an improved platform for the selection and production of antibody fragments.

24 October

2020

KS8 Conference On-Line 24.10.2020

The KS8 On-Line Conference organized by Longterm took place on October 24, 2020.

9 October

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

17 June

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

10 April

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

25 January

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

21 January

2020